|
Posted by: thepinetree on 11/23/2020 10:29 PM
Updated by: thepinetree on 11/23/2020 10:29 PM
Expires: 01/01/2025 12:00 AM
:
Oxford - AstraZeneca Covid Vaccine 90% Effective in Some Trials
Cambridge, United Kingdom...Two different dosing regimens demonstrated efficacy with one showing a better profile. No hospitalisations or severe cases of COVID-19 in participants treated with AZD1222. Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine. There were a total of 131 COVID-19 cases in the interim analysis.
One dosing regimen (n=2,741) showed vaccine efficacy of 90% when AZD1222 was given as a half dose, followed by a full dose at least one month apart, and another dosing regimen (n=8,895) showed 62% efficacy when given as two full doses at least one month apart. The combined analysis from both dosing regimens (n=11,636) resulted in an average efficacy of 70%. All results were statistically significant (p
|
| Comments - Make a comment |
| The comments are owned by the poster. We are not responsible for its content. We value free speech but remember this is a public forum and we hope that people would use common sense and decency. If you see an offensive comment please email us at news@thepinetree.net
|
| What's Related |
| These might interest you as well
Photo Albums
Local News
Calendar
phpws Business Directory
RSS News Feeds
Web Pages
|
|
|
